A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients

This study is ongoing, but not recruiting participants.

Study NCT00113412 Information provided by Samaritan Pharmaceuticals, Inc

First Received: June 7, 2005 Last Updated: March 21, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given